Clinical Trial

A Study to Evaluate the Safety of HS-10506 in Chinese Patients With Insomnia Disorder

Name: A Study to Evaluate the Safety of HS-10506 in Chinese Patients With Insomnia Disorder — clinical trial record (NCT07677384)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The primary purpose of this open-label phase Ⅲ study is to evaluate the safety of HS-10506 on the incidence and severity of adverse events (AE), serious adverse events (SAE), adverse events of special interest (AESI) in Chinese adult participants with insomnia disorder.

Trial Details

NCT Number	NCT07677384
Lead Sponsor	Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions	Insomnia Disorder
Enrollment	600 participants
Start Date	2026-06-12
Primary Completion	2029-06-30 (estimated)
Study Completion	2029-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-30